Covered recipient · General Payments record
AMBER MICHELLE MORELAND
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,888.06
- Reported across 182 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $596.78 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $434.24 | 28 |
| Medtronic, Inc. | $69.71 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.98 | 1 |
| Janssen Biotech, Inc. | $19.89 | 1 |
| Gilead Sciences, Inc. | $18.45 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $17.23 | 1 |
| SANOFI PASTEUR INC. | $13.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.40 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064466 | CMS |
| ABBVIE INC. | $15.95 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064468 | CMS |
| ABBVIE INC. | $20.12 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064470 | CMS |
| ABBVIE INC. | $11.33 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064472 | CMS |
| ABBVIE INC. | $6.33 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064474 | CMS |
| ABBVIE INC. | $12.64 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064476 | CMS |
| ABBVIE INC. | $10.18 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064478 | CMS |
| ABBVIE INC. | $8.30 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064480 | CMS |
| ABBVIE INC. | $19.85 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064482 | CMS |
| ABBVIE INC. | $9.29 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064484 | CMS |
| ABBVIE INC. | $10.93 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064486 | CMS |
| ABBVIE INC. | $17.72 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064488 | CMS |
| ABBVIE INC. | $9.72 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064490 | CMS |
| ABBVIE INC. | $21.24 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064492 | CMS |
| ABBVIE INC. | $16.57 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064494 | CMS |
| ABBVIE INC. | $18.83 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064496 | CMS |
| ABBVIE INC. | $10.29 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064498 | CMS |
| ABBVIE INC. | $21.07 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064500 | CMS |
| ABBVIE INC. | $15.91 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064502 | CMS |
| ABBVIE INC. | $20.65 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064504 | CMS |
| ABBVIE INC. | $18.18 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064506 | CMS |
| ABBVIE INC. | $14.90 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064508 | CMS |
| ABBVIE INC. | $13.97 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064510 | CMS |
| ABBVIE INC. | $23.08 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064512 | CMS |
| ABBVIE INC. | $18.92 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064514 | CMS |
| ABBVIE INC. | $10.23 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064516 | CMS |
| ABBVIE INC. | $20.52 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064518 | CMS |
| ABBVIE INC. | $23.12 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064520 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.23 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146995452 | CMS |
| Gilead Sciences, Inc. | $18.45 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133786707 | CMS |
| Janssen Biotech, Inc. | $19.89 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078753963 | CMS |
| Medtronic, Inc. | $69.71 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117047636 | CMS |
| SANOFI PASTEUR INC. | $13.28 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128747653 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.98 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137638216 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.